Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat

Objectives: Ritonavir and cobicistat are strong inhibitors of human cytochrome P450-3A (CYP3A) isoforms, and are used clinically as pharmacokinetic boosting agents for other antiretroviral drugs. Data reported by the manufacturer suggest that cobicistat is a more selective inhibitor of CYP3A than ri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hossain, Md. Amin (VerfasserIn) , Mikus, Gerd (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 September 2017
In: Journal of pharmacy and pharmacology
Year: 2017, Jahrgang: 69, Heft: 12, Pages: 1786-1793
ISSN:2042-7158
DOI:10.1111/jphp.12820
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1111/jphp.12820
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/jphp.12820
Volltext
Verfasserangaben:Md Amin Hossain, Timothy Tran, Tianmeng Chen, Gerd Mikus and David J. Greenblatt

MARC

LEADER 00000caa a2200000 c 4500
001 1580848478
003 DE-627
005 20220815004700.0
007 cr uuu---uuuuu
008 180911s2017 xx |||||o 00| ||eng c
024 7 |a 10.1111/jphp.12820  |2 doi 
035 |a (DE-627)1580848478 
035 |a (DE-576)510848478 
035 |a (DE-599)BSZ510848478 
035 |a (OCoLC)1341018303 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hossain, Md. Amin  |e VerfasserIn  |0 (DE-588)1166686051  |0 (DE-627)1030551081  |0 (DE-576)510848591  |4 aut 
245 1 0 |a Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat  |c Md Amin Hossain, Timothy Tran, Tianmeng Chen, Gerd Mikus and David J. Greenblatt 
264 1 |c 29 September 2017 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.09.2018 
520 |a Objectives: Ritonavir and cobicistat are strong inhibitors of human cytochrome P450-3A (CYP3A) isoforms, and are used clinically as pharmacokinetic boosting agents for other antiretroviral drugs. Data reported by the manufacturer suggest that cobicistat is a more selective inhibitor of CYP3A than ritonavir. However, this claim has not been validated in clinical studies. This study evaluated the in-vitro inhibitory potency of ritonavir and cobicistat vs a series of human CYP isoforms. Method: The model system utilized human liver microsomes and isoform-selective index substrates. Key findings: Ritonavir and cobicistat both were strong inhibitors of CYP3A4, with IC50 values of 0.014 and 0.032 μm, respectively. A component of inhibition was time-dependent (mechanism-based). Neither drug meaningfully inhibited CYP1A2 (IC50 > 150 μm). CYP2B6, CYP2C9, CYP2C19 and CYP2D6 were inhibited by both drugs, but with IC50 values exceeding 6 μm. Conclusions: Consistent with previous reports, both ritonavir and cobicistat were highly potent inhibitors of CYP3A. Both drugs were weaker inhibitors of other human CYPs, with IC50 values at least two orders of magnitude higher. There was no evidence of a meaningful difference in selectivity between the two drugs. 
650 4 |a cobicistat 
650 4 |a cytochromes P450 
650 4 |a in-vitro metabolism 
650 4 |a metabolic inhibition 
650 4 |a ritonavir 
700 1 |a Mikus, Gerd  |e VerfasserIn  |0 (DE-588)110903137  |0 (DE-627)691097941  |0 (DE-576)336988710  |4 aut 
773 0 8 |i Enthalten in  |t Journal of pharmacy and pharmacology  |d Oxford : Oxford University Press, 1949  |g 69(2017), 12, Seite 1786-1793  |h Online-Ressource  |w (DE-627)326977740  |w (DE-600)2041988-0  |w (DE-576)094504156  |x 2042-7158  |7 nnas  |a Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat 
773 1 8 |g volume:69  |g year:2017  |g number:12  |g pages:1786-1793  |g extent:8  |a Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat 
856 4 0 |u http://dx.doi.org/10.1111/jphp.12820  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/jphp.12820  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180911 
993 |a Article 
994 |a 2017 
998 |g 110903137  |a Mikus, Gerd  |m 110903137:Mikus, Gerd  |d 910000  |d 910100  |e 910000PM110903137  |e 910100PM110903137  |k 0/910000/  |k 1/910000/910100/  |p 4 
999 |a KXP-PPN1580848478  |e 3025250798 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat","title_sort":"Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat"}],"person":[{"family":"Hossain","given":"Md. Amin","display":"Hossain, Md. Amin","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Mikus, Gerd","roleDisplay":"VerfasserIn","role":"aut","family":"Mikus","given":"Gerd"}],"recId":"1580848478","language":["eng"],"note":["Gesehen am 11.09.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1111/jphp.12820"],"eki":["1580848478"]},"origin":[{"dateIssuedDisp":"29 September 2017","dateIssuedKey":"2017"}],"name":{"displayForm":["Md Amin Hossain, Timothy Tran, Tianmeng Chen, Gerd Mikus and David J. Greenblatt"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["2042-7158"],"doi":["10.1111/(ISSN)2042-7158"],"eki":["326977740"],"zdb":["2041988-0"]},"origin":[{"publisherPlace":"Oxford ; London ; Oxford [u.a.]","publisher":"Oxford University Press ; Pharmaceutical Press ; Wiley-Blackwell","dateIssuedKey":"1949","dateIssuedDisp":"1949-"}],"language":["eng"],"recId":"326977740","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistatJournal of pharmacy and pharmacology","note":["Gesehen am 09.07.24"],"titleAlt":[{"title":"JPP"}],"part":{"issue":"12","pages":"1786-1793","year":"2017","extent":"8","text":"69(2017), 12, Seite 1786-1793","volume":"69"},"pubHistory":["1.1949 -"],"title":[{"title_sort":"Journal of pharmacy and pharmacology","subtitle":"JPP ; an international journal of pharmaceutical science","title":"Journal of pharmacy and pharmacology"}]}],"physDesc":[{"extent":"8 S."}]} 
SRT |a HOSSAINMDAINHIBITION2920